Expres 10 mg (Tablet)
Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00
Medicine Details
Category | Details |
---|---|
Generic | Escitalopram oxalate |
Company | Synovia pharma plc |
Also available as |
Indications
- Treatment of major depressive episodes
- Treatment of panic disorder with or without agoraphobia
- Treatment of social anxiety disorder (social phobia)
- Treatment of generalised anxiety disorder
- Treatment of obsessive-compulsive disorder
Pharmacology
- Escitalopram is an orally administered selective serotonin reuptake inhibitor (SSRI)
- Escitalopram is the pure S-enantiomer of the racemic bicyclic phthalate derivative citalopram
- Escitalopram is at least 100 fold more potent than the R-enantiomer with respect to inhibition of 5-HT reuptake
- Escitalopram has no or very low affinity for serotonergic or other receptors including alpha- and beta-adrenergic, Dopamine, Histamine, Muscarinic, and benzodiazepine receptors
Dosage
- Safety of daily doses above 20 mg has not been demonstrated
- Usual dosage for major depressive episodes is 10 mg once daily, may be increased to a maximum of 20 mg daily
- Usual dosage for panic disorder is 5 mg for first week, before increasing to 10 mg daily, may further increase to a maximum of 20 mg daily
- Usual dosage for social anxiety disorder is 10 mg once daily, dose may be decreased to 5 mg or increased to a maximum of 20 mg daily
- Usual dosage for generalised anxiety disorder is 10 mg once daily, may be increased to a maximum of 20 mg daily
- Usual dosage for obsessive-compulsive disorder is 10 mg once daily, may be increased to a maximum of 20 mg daily
Administration
- Escitalopram should generally be administered once daily, morning or evening, with or without food
Interaction
- SSRI or related antidepressants should not be started until 2 weeks after stopping an MAOI
- An MAOI should not be started until at least a week after an SSRI or related antidepressant has been stopped (2 weeks in the case of paroxetine and sertraline, at least 5 weeks in the case of fluoxetine)
Contraindications
- Escitalopram is contraindicated in patients with known hypersensitivity to Escitalopram or Citalopram or any of the inactive ingredients of the drug product
- Concomitant use of escitalopram in patients taking monoamine oxidase/pimozide is contraindicated
Side Effects
- Less sedating and have fewer antimuscarinic and cardiotoxic effects than tricyclic antidepressants
- Side-effects of the SSRIs include gastrointestinal effects, anorexia with weight loss or increased appetite and weight gain, hypersensitivity reactions, dry mouth, nervousness, anxiety, headache, insomnia, tremor, dizziness, asthenia, hallucinations, drowsiness, convulsions, galactorrhoea, sexual dysfunction, urinary retention, sweating, hypomania or mania, movement disorders and dyskinesias, visual disturbances
Pregnancy & Lactation
- Potential risks and benefits of treatment should be carefully considered when treating a pregnant woman with Escitalopram during the third trimester
- Excreted in human breast milk, decision whether to continue or discontinue either nursing or Escitalopram therapy should take into account the risk of citalopram exposure for the infant and the benefits of Escitalopram treatment for the mother
Precautions & Warnings
- SSRIs should be used with caution in patients with epilepsy, history of mania, cardiac disease, diabetes mellitus, angle-closure glaucoma, concomitant use of drugs that increase risk of bleeding, history of bleeding disorders, hepatic and renal impairment
Use in Special Populations
- Elderly patients (>65 years of age) should start with an initial dosage of 5 mg once daily, may be increased to 10 mg daily
- Expres should not be used in the treatment of children and adolescents under the age of 18 years
- Dosage adjustment is not necessary in patients with mild or moderate renal impairment, caution advised in patients with severely reduced renal function
- An initial dose of 5 mg daily for the first two weeks of treatment is recommended in patients with mild or moderate hepatic impairment, depending on individual patient response, the dose may be increased to 10 mg daily
- For patients who are known to be poor metabolisers with respect to CYP2C19, an initial dose of 5 mg daily during the first two weeks of treatment is recommended, depending on individual patient response, the dose may be increased to 10 mg daily
Overdose Effects
- Symptoms seen in a reported overdose of escitalopram include symptoms mainly related to the central nervous system, the gastrointestinal system, the cardiovascular system, and electrolyte/fluid balance conditions
- There is no specific antidote, general symptomatic supportive measures are recommended
Therapeutic Class
- SSRIs & related anti-depressant drugs
Storage Conditions
- Store below 30°C temperature and protect from light & moisture
- Keep the medicine out of the reach of children